News
GNGBF
20.22
NaN%
--
Getinge AB Non-GAAP EPS of €0.46, revenue of €520.1M; initiates FY25 outlook
Seeking Alpha · 5d ago
Weekly Report: what happened at GNGBF last week (0414-0418)?
Weekly Report · 6d ago
Weekly Report: what happened at GNGBF last week (0407-0411)?
Weekly Report · 04/14 10:11
Weekly Report: what happened at GNGBF last week (0331-0404)?
Weekly Report · 04/07 10:11
Protean Funds Scandinavia AB March 2025 Partner Letter
Seeking Alpha · 04/02 14:35
Weekly Report: what happened at GNGBF last week (0324-0328)?
Weekly Report · 03/31 10:17
Weekly Report: what happened at GNGBF last week (0317-0321)?
Weekly Report · 03/24 10:11
Weekly Report: what happened at GNGBF last week (0310-0314)?
Weekly Report · 03/17 10:16
Weekly Report: what happened at GNGBF last week (0303-0307)?
Weekly Report · 03/10 10:17
Weekly Report: what happened at GNGBF last week (0224-0228)?
Weekly Report · 03/03 10:17
Weekly Report: what happened at GNGBF last week (0217-0221)?
Weekly Report · 02/24 10:17
Weekly Report: what happened at GNGBF last week (0210-0214)?
Weekly Report · 02/17 10:16
Weekly Report: what happened at GNGBF last week (0203-0207)?
Weekly Report · 02/10 10:12
Protean Funds Scandinavia AB January 2025 Partner Letter
Seeking Alpha · 02/04 06:45
Weekly Report: what happened at GNGBF last week (0127-0131)?
Weekly Report · 02/03 10:15
Getinge AB Non-GAAP EPS of SEK 5.28, revenue of SEK 11.07B; initiates FY25 outlook
Seeking Alpha · 01/28 09:13
Weekly Report: what happened at GNGBF last week (0120-0124)?
Weekly Report · 01/27 10:16
Weekly Report: what happened at GNGBF last week (0113-0117)?
Weekly Report · 01/20 10:12
Weekly Report: what happened at GNGBF last week (0106-0110)?
Weekly Report · 01/13 10:13
Protean Funds Scandinavia AB December 2024 Partner Letter
Seeking Alpha · 01/08 11:45
More
Webull provides a variety of real-time GNGBF stock news. You can receive the latest news about Getinge through multiple platforms. This information may help you make smarter investment decisions.
About GNGBF
Getinge AB is a Sweden-based company operating within healthcare sector. The Company provides hospitals and Life Science institutions with products and solutions aimed at improving clinical outcomes and optimizing workflows. The Company’s reporting segments have the following activities: Acute Care Therapies develops solutions for life-sustaining care in acute health conditions. Life Science offers a comprehensive range of equipment, technical expertise and prevention consultation contamination in pharmaceutical production, biomedical research, production of medical equipment and in various laboratory applications. Surgical Workflows offers products and services for the effective disinfection and sterilization of instruments used in operations, operating tables and others hardware for operating rooms and advanced IT systems for efficient and secure workflows in hospitals.